The global dermatology imaging devices market size is anticipated to reach USD 5.60 billion by 2030 and it is projected to grow at a CAGR of 13.09% from 2024 to 2030, according to a new report by Grand View Research, Inc. The growing prevalence of skin disorders such as cancer, and inflammatory dermatoses, among others are the major contributing factors for market growth. For instance, according to the International Agency for Research on Cancer, in 2022, globally 331, 722 cases of melanoma cancer were reported, the cases are further estimated to reach 1,262,756 by 2027. Furthermore, technological advancements are also expected to propel market growth.
Dermatology imaging devices are efficient as they provide non-invasive, high-resolution visualization of skin lesions and other related conditions. They help dermatologists by providing detailed morphology, structure, and traits of diverse skin abnormalities, which thereby help in precise diagnosis and treatment strategizing. Moreover, they enable remote consultation, assist specialists to exchange images and expertise, thereby enhancing patient care.
Technological advancements in dermatology imaging devices such as high-resolution images, integration with AI, 3D imaging are further expected to contribute to the market growth. For instance, ,in June 2023, FotoFinder Systems GmbH, a prominent manufacturer of medical imaging systems for dermatology, has recently unveiled two new cutting-edge innovations - the meesma, a portable imaging solution for aesthetics, and the fourth generation FotoFinder ATBM master equipped with an AI assistant called AIMEE for Total Body Dermoscopy. These state-of-the-art systems are showcased for the first time to experts at the "25th World Congress of Dermatology" (WCD) in Singapore, scheduled from 3rd to 8th July 2023.
Market participants are implementing a range of strategic initiatives to maintain competitiveness and expand their market share. These initiatives include product launch, government approval, expansion, partnership, merger, and acquisitions. In May 2023,Orlucent's skin fluorescence imaging system has been granted Breakthrough Device Designation (BDD) by the US Food and Drug Administration (FDA).t's a handheld point-of-care device that provides molecular-level imaging and analysis of moles. This innovative tool can identify and assess biological tissue-remodeling activity associated with the development of abnormal moles in adults, all without requiring invasive procedures.
Request a free sample copy or view report summary: Dermatology Imaging Devices Market Report
Based on modality, the dermatoscope segment led the market with the largest revenue share of 41.42% in 2023, Also, the digital photographic imaging segment is anticipated to grow at the fastest CAGR during the forecast period
Based on application, the skin cancer segment held the market with the largest revenue share of 48.63% in 2023. On other hand, the plastic and reconstructive surgery segment is expected to grow at the fastest CAGR during the forecast period
Based on end-use, the hospitals held the market with the largest revenue share of 43.99% in 2023. And, the dermatology centers segment is expected to grow at a fastest CAGR over the forecast period.
North America dominated the market with the revenue share of 39.48% in 2023.
Grand View Research has segmented the global dermatology imaging devices market based on the modality, application, end use, and regions:
Dermatology Imaging Devices Modality Outlook (Revenue, USD Million, 2018 - 2030)
Digital Photographic Imaging
Optical Coherence Tomography (OCT)
Dermatoscope
High Frequency Ultrasound
Others
Dermatology Imaging Devices Application Outlook (Revenue, USD Million, 2018 - 2030)
Skin Cancers
Inflammatory Dermatoses
Skin psoriasis
Eczema (Atopic dermatitis)
Others
Plastic and Reconstructive Surgery
Others
Dermatology Imaging Devices End-use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals
Dermatology Centers
Specialty Clinics
Dermatology Imaging Devices Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
Thailand
South Korea
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in the Dermatology Imaging Devices Market
Canfield Scientific, Inc.
FotoFinder Systems GmbH
e-con Systems Inc.
Courage+Khazaka electronic GmbH
Longport, Inc.
Cortex Technology
DRAMINSKI S. A.
GE HealthCare
VisualSonics
Clarius
Koninklijke Philips N.V.
Michelson Diagnostics Ltd (MDL)
Caliber Imaging and Diagnosis.
DermLite
"The quality of research they have done for us has been excellent..."